A detailed history of Bio Impact Capital LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 289,396 shares of RVMD stock, worth $13.1 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares
289,396
Previous 273,217 5.92%
Holding current value
$13.1 Million
Previous $8.81 Million 27.55%
% of portfolio
1.8%
Previous 1.44%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$30.14 - $40.68 $487,635 - $658,161
16,179 Added 5.92%
289,396 $11.2 Million
Q1 2024

May 15, 2024

SELL
$26.56 - $33.55 $5,072 - $6,408
-191 Reduced 0.07%
273,217 $8.81 Million
Q2 2023

Aug 14, 2023

BUY
$20.28 - $27.0 $535,108 - $712,422
26,386 Added 10.68%
273,408 $7.31 Million
Q1 2023

May 12, 2023

BUY
$20.76 - $30.09 $2.03 Million - $2.95 Million
97,979 Added 65.74%
247,022 $5.35 Million
Q4 2022

Feb 14, 2023

BUY
$17.68 - $25.53 $53,075 - $76,641
3,002 Added 2.06%
149,043 $3.55 Million
Q4 2021

Feb 11, 2022

SELL
$24.35 - $33.7 $96,401 - $133,418
-3,959 Reduced 2.64%
146,041 $3.68 Million
Q3 2021

Nov 15, 2021

BUY
$23.95 - $33.41 $3.59 Million - $5.01 Million
150,000 New
150,000 $4.13 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.96B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.